Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle)

Journal of Veterinary Pharmacology and Therapeutics

Volumn 35, Issue 6, 2012, Pages 550-559

  Menge, M ^a   Rose, M ^a   Bohland, C ^a   Zschiesche, E ^a   Kilp, S ^a   Metz, W ^a   Allan, M ^a   Ropke R ^a   Nurnberger M ^a  

^a Intervet Innovation GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TILDIPIROSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CATTLE; CATTLE DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; LUNG FLUID; LUNG HOMOGENATE; LUNG PARENCHYMA; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BRONCHOALVEOLAR LAVAGE FLUID; CATTLE; FEMALE; HALF-LIFE; LUNG; MALE; MOLECULAR STRUCTURE; TYLOSIN;

BOS; BOVINAE;

EID: 84867509413     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2011.01349.x     Document Type: Article

References (32)

1. Anadón, A. & Reeve-Johnson, L. (1999) Macrolide antibiotics, drug interactions and microsomal enzymes: implications for veterinary medicine. Research in Veterinary Science, 66, 197-203.
2. Cox, S.R., McLaughlin, C., Fielder, A.E., Yancey, M.F., Bowersock, T.L., Garcia-Tapia, D., Bryson, L., Lucas, M.J., Robinson, J.A., Nanjiani, I. & Brown, S.A. (2010) Rapid and prolonged distribution of tulathromycin into lung homogenate and pulmonary epithelial lining fluid of Holstein calves following a single subcutaneous administration of 2.5mg/kg body weight. International Journal of Applied Research in Veterinary Medicine, 8, 129-137.
3. Cusack, P.M. (2004) Effect of mass medication with antibiotics at feedlot entry on the health and growth rate of cattle destined for the Australian domestic market. Australian Veterinary Journal, 82, 154-156.
4. Duff, G.C. & Galyean, M.L. (2007) Board-invited review: recent advances in management of highly stressed, newly received feedlot cattle. Journal of Animal Science, 85, 823-840.
5. Edwards, T.A. (2010) Control methods for bovine respiratory disease for feedlot cattle. Journal of Veterinary Clinics of North America: Food Animal Practice, 26, 273-284.
6. EMA. (2011) CVMP assessment report Zuprevo (EMEA/V/C/002009) http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/medicines/002009/vet_med_000242.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001fa1c (last accessed 30 May 2011).
7. Gay, E. & Barnouin, J. (2009) A nation-wide epidemiological study of acute bovine respiratory disease in France. Preventive Veterinary Medicine, 89, 265-271.
8. Giguère, S., Huang, R., Malinski, T.J., Dorr, P.M., Tessman, R.K. & Sommerville, B.A. (2011) Disposition of gamithromycin in plasma, pulmonary epithelial lining fluid, bronchoalveolar cells, and lung tissue in cattle. American Journal of Veterinary Research, 72, 326-330.
9. Gladue, R.P., Bright, G.M., Isaacson, R.E. & Newborg, M.F. (1989) In vitro and in vivo uptake of azithromycin (CP-62, 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrobial Agents Chemotherapy, 33, 277-282.
10. Godinho, K.S. (2008) Susceptibility testing of tulathromycin: interpretative breakpoints and susceptibility of field isolates. Veterinary Microbiology, 129, 426-432.
11. Halstead, S.L., Walker, R.D., Baker, J.C., Holland, R.E., Stein, G.E. & Hauptman, J.G. (1991) Pharmacokinetic evaluation of ceftiofur in serum, tissue chamber fluid and bronchial secretions from healthy beef-bred calves. Canadian Journal of Veterinary Research, 56, 269-274.
12. Huang, R.A., Letendre, L.T., Banav, N., Fischer, J. & Somerville, B. (2010) Pharmacokinetics of gamithromycin in cattle with comparison of plasma and lung tissue concentrations and plasma antibacterial activity. Journal of Veterinary Pharmacology and Therapeutics, 33, 227-237.
13. Kiem, S. & Schentag, J.J. (2008) Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrobial Agents Chemotherapy, 52, 24-36.
14. Lees, P., Concordet, D., Aliabadi, F.S. & Toutain, P.L. (2006) Drug selection and optimization of dosage schedules to minimize antimicrobial resistance. In Antimicrobial Resistance in Bacteria of Animal Origin. Ed. Aarestrup, F.M., pp. 49-60. ASM Press, Washington, DC, USA.
15. Lekeux, P. (1995) Bovine respiratory disease complex: a European perspective. Bovine Practitioner, 29, 71-75.
16. Lombardi, K.R., Portillo, T., Hassfurther, R. & Hunter, R.P. (2011) Pharmacokinetics of timicosin in beef cattle following intravenous and subcutaneous administration. Journal of Veterinary Pharmacology and Therapeutics, 34, 583-587.
17. McKellar, Q.A., Sanchez Bruni, S.F. & Jones, D.G. (2004) Pharmacokinetic/pharmacodynamic relation ship of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503-514.
18. Modric, S., Webb, A.I. & Dehrendorf, H. (1998) Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. Journal of Veterinary Pharmacology and Therapeutics, 21, 444-452.
19. Mouton, J.W., Theuertzbacher, U., Craig, W.A., Tulkens, P.M., Derendorf, H. & Cars, O. (2008) Tissue concentrations: do ever learn? Journal of Antimicrobial Chemotherapy, 61, 235-237.
20. Müller, M., dela Pena, A. & Derendorf, H. (2004) Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrobial Agents Chemotherapy, 48, 1441-1453.
21. Nightingale, C.H. (1997) Pharmacokinetics and pharmacodynamics of newer macrolides. Pediatric Infectious Disease Journal, 16, 438-443.
22. Nowakowski, M.A., Inskeep, P.B., Risk, J.E., Skogerboe, T.L., Benchaoui, H.A., Meinert, T.R., Sherington, J. & Sunderland, S.J. (2004) Pharmacokinetics and lung tissue concentrations of tulathromycin, a novel triamilide antibiotic in cattle. Veterinary Therapeutics, 5, 60-74.
23. Schluenzen, F., Zarivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., Yonath, A. & Franceschi, F. (2001) Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature, 413, 814-821.
24. Scorneaux, B. & Shryock, T.R. (1999) Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. Journal of Dairy Science., 82, 1202-1212.
25. Shryock, T.R., White, D.W., Staples, J.M. & Werner, C.S. (1996) Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease. Journal of Veterinary Diagnostic Investigations, 8, 337-344.
26. Stratton, C.W. (2005) Molecular mechanisms of action for antimicrobial agents: general principles and mechanisms for selected classes of antibiotics. In Antibiotics in Laboratory Medicine, 5th edn. Ed. Lorian, V., pp. 547-549. Lippincott Williams and Wilkins, Philadelphia, PA, USA.
27. Toutain, P.L. (2009) PK/PD approach for antibiotics: tissue or blood drug levels to predict antibiotic efficacy. Journal of Veterinary Pharmacology and Therapeutics, 32 (Suppl. 1), 19-21.
28. Toutain, P.L. & Bousquet-Mélou, A. (2004) Bioavailability and its assessment. Journal of Veterinary Pharmacology and Therapeutics, 27, 455-466.
29. Toutain, P.L., Bousquet-Mélou, A. & Martinez, M. (2007) AUC/MIC: a PK/PD index for antibiotics with a time dimensionless scoring factor? Journal of Antimicrobial Chemotherapy, 60, 1185-1188.
30. Van Bambeke, F. & Tulkens, P.M. (2001) Macrolides: pharmacokinetics and pharmacodynamics. International Journal of Antimicrobial Agents, 18, S17-S23.
31. Venner, M., Peters, J., Höhensteiger, N., Schock, B., Bornhorst, A., Grube, M., Adam, U., Scheuch, E., Weitschies, W., Rosskopf, D., Kroemer, H.K. & Siegmund, W. (2010) Concentration oft the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals. Naunyn-Schmiedebergs Archives of Pharmacology, 381, 161-169.
32. Zeitlinger, M., Mueller, M. & Joukhadar, C. (2005) Lung microdialysis - a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review). The AAPS Journal, 7, E600-E608.